Wolfe Research Downgrades Edwards Lifesciences to Underperform, Announces $57 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wolfe Research analyst Mike Polark has downgraded Edwards Lifesciences (NYSE:EW) from Peer Perform to Underperform and set a price target of $57.
November 28, 2023 | 10:27 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Edwards Lifesciences was downgraded by Wolfe Research from Peer Perform to Underperform with a new price target of $57.
Downgrades by analysts can lead to a negative perception among investors and potentially cause a short-term decline in the stock's price. The new price target of $57 suggests a bearish outlook on the stock's future performance.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100